These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9159409)

  • 1. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice.
    Miyoshi-Akiyama T; Fujimaki W; Yan XJ; Yagi J; Imanishi K; Kato H; Tomonari K; Uchiyama T
    Microbiol Immunol; 1997; 41(4):345-52. PubMed ID: 9159409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
    Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
    Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.
    Goubard A; Loïez C; Abe J; Fichel C; Herwegh S; Faveeuw C; Porte R; Cayet D; Sebbane F; Penet S; Foligné B; Desreumaux P; Saito H; Sirard JC; Simonet M; Carnoy C
    Infect Immun; 2015 May; 83(5):2053-64. PubMed ID: 25754199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
    Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
    J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
    Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
    J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
    Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
    J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells.
    Chen L; Koyanagi M; Fukada K; Imanishi K; Yagi J; Kato H; Miyoshi-Akiyama T; Zhang R; Miwa K; Uchiyama T
    J Immunol; 2002 Apr; 168(8):3817-24. PubMed ID: 11937534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
    Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
    Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells.
    Jiang H; Kashleva H; Xu LX; Forman J; Flaherty L; Pernis B; Braunstein NS; Chess L
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4533-7. PubMed ID: 9539772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (Vbeta8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens.
    Kreiss M; Asmuss A; Krejci K; Lindemann D; Miyoshi-Akiyama T; Uchiyama T; Rink L; Broeren CP; Herrmann T
    Int Immunol; 2004 May; 16(5):655-63. PubMed ID: 15096488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
    Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
    Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen.
    Seprényi G; Ito Y; Kohsaka T
    Cell Immunol; 1999 Mar; 192(2):96-106. PubMed ID: 10087177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen.
    Donnelly GA; Lu J; Takeda T; McKay DM
    J Infect Dis; 1999 Nov; 180(5):1590-6. PubMed ID: 10515820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
    Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
    J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant Disruption of
    Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
    J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
    Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
    Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
    Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
    FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.